Healthcare Realty Trust Signals Turnaround In Earnings Call
Healthcare Realty Trust Incorporated ((HR)) has held its Q4 earnings call. Read on for the main highlights of the call.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Healthcare Realty Trust’s latest earnings call painted the picture of a company in the midst of a convincing turnaround. Management emphasized stronger leasing, disciplined asset sales, margin gains, and real balance sheet repair, even as near-term FFO appears muted by deliberate deleveraging and refinancing costs. Execution momentum and improving fundamentals clearly outweighed the remaining headwinds.
Same-Store Outperformance and Solid FFO Delivery
Healthcare Realty reported full-year same-store NOI growth of 4.8% for 2025 and 5.5% same-store cash NOI growth in the fourth quarter. Normalized FFO per share reached $1.61 for the year, $0.03 above the midpoint of prior guidance, with Q4 normalized FFO coming in at $0.40.
Leasing Momentum and Strengthening Metrics
The company executed roughly 5.8 million square feet of leasing during 2025, including about 1.6 million square feet of new leases, with 1.5 million square feet signed in the fourth quarter alone. Annual rent escalators on these leases averaged 3.1%, lease terms averaged about six years, and tenant retention improved to 82% for the year and around 83% in Q4.
Revamped Asset Management Boosting Economics
A new asset management platform is translating into better economics across the portfolio, including a 60 basis point improvement in cash leasing spreads. Tenant retention improved by 220 basis points, and management highlighted better lease IRRs and faster payback periods as evidence of early success.
Redevelopment Program Aimed at Double-Digit Yields
Healthcare Realty is targeting around 10% yields on cost from its redevelopment pipeline, which saw leasing levels improve by about 1,000 basis points since the third quarter. The company has identified roughly $15 million of the planned $50 million redevelopment NOI upside so far, supported by lease-up wins such as a 64,000 square foot deal at St. Peter’s.
Large Disposition Program and Market Repositioning
The REIT completed approximately $1.2 billion of asset sales at a blended 6.7% cap rate, surpassing its own expectations. Those sales enabled an exit from 14 noncore markets and sharpened exposure to higher-growth metropolitan areas, with about $700 million of fourth-quarter dispositions helping to fund debt reduction.
Balance Sheet Repair and Upgraded Outlooks
Net debt to EBITDA fell from 6.4 times to 5.4 times as the company repaid about $900 million of debt, including bonds and term loans. Maturity profiles were extended, liquidity improved, and both Moody’s and S&P shifted their outlooks on the company’s ratings to Stable.
G&A Discipline and Margin Expansion
Management reached its targeted $10 million run-rate reduction in general and administrative expense, bringing total G&A down to about $45 million. Property-level NOI margins improved by 60 basis points, and the team expressed confidence that further incremental margin expansion is achievable.
Capital Returns and Selective Buybacks
The dividend was reset to a level that currently yields roughly 6%, with fourth-quarter FAD per share of $0.32 and a payout ratio near 75%. The company repurchased $50 million of stock in January, or about 2.9 million shares, and still has $450 million remaining under its share repurchase authorization.
Leasing Pipeline and Health System Demand
An active leasing pipeline of around 1.3 million square feet underscores ongoing tenant demand, particularly from major health systems. Management cited large renewals and extensions with systems such as Tufts and Advocate and highlighted near-full occupancy in certain relationships, including a Baptist portfolio that is roughly 99% leased.
Cost of Capital and Leverage Constraints
Despite progress, leverage remains in the mid-5 times net debt to EBITDA range, which constrains flexibility and encourages conservative capital allocation. Management noted that high capital costs and a discount to intrinsic asset values mean new acquisitions would generally need cap rates in the low 7% range, making most deals unattractive without creative structures.
Capex Intensity and Redevelopment Spend
Maintenance and second-generation leasing capex currently run in the 15% to 20% of NOI range, consistent with historical levels. On top of that, the company is committing significant funds to its redevelopment pipeline, which pressures near-term free cash but is expected to deliver higher long-term cash flows.
Organizational Changes Behind the Turnaround
To rightsize the cost structure, Healthcare Realty implemented difficult personnel reductions and broader organizational changes. Management acknowledged these as challenging but necessary steps to support the new asset management model, margin improvements, and the broader strategic turnaround.
Guidance: Core Growth Masked by Deleveraging
For 2026, the company guided normalized FFO to a range of $1.58 to $1.64 per share, with a midpoint of $1.61 implying flat reported FFO versus 2025 as core growth offsets dilution from prior asset sales and deleveraging. Guidance assumes same-store cash NOI growth of 3.5% to 4.5%, G&A of $43 million to $47 million, about $100 million of post-dividend free cash flow, roughly $175 million of asset sales, refinancing of $600 million of August bonds at a low-5% coupon, use of a new $600 million commercial paper program, leverage remaining in the mid-5 times range, and no incremental acquisitions, developments, or additional share buybacks.
Healthcare Realty’s earnings call delivered a clear message of operational progress and strategic discipline, even if the headline FFO guidance appears flat. Investors will need to weigh the near-term drag from deleveraging and refinancing against improving leasing fundamentals, higher margins, and a healthier balance sheet that could support more offensive moves once capital markets become more favorable.
